Drug-Coated Balloons for the Dysfunctional Vascular Access: An Evidence-Based Road Map to Treatment and the Existing Obstacles

Overview

Journal Semin Intervent Radiol

Specialty Radiology

Date 2022 Feb 25

PMID 35210734

Authors

Panagiotis Kitrou

Konstantinos Katsanos

Georgia Andriana Georgopoulou

Dimitrios Karnabatidis

Affiliations

Soon will be listed here.

Abstract

An underlying stenosis within the venous limb of a hemodialysis access circuit is the main etiology for graft and fistula dysfunction as well as other symptoms such as arm, breast, and neck swelling. Treatment options for both peripheral and central venous stenoses include plain old balloon angioplasty, angioplasty with drug-coated balloons, and stenting. This article discusses the current evidence for the use of drug-coated balloon angioplasty in this patient population.

Citing Articles

Existing and Evolving Therapies for Arteriovenous Fistula and Graft Dysfunction.

Vachharajani T, Bhargava V, Sequeira A, Meena P Indian J Nephrol. 2024; 34(6):552-560.

PMID: 39649313 PMC: 11619062. DOI: 10.25259/ijn_528_23.

Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy.

Shazly T, Eberth J, Kostelnik C, Uline M, Chitalia V, Spinale F ACS Appl Bio Mater. 2024; 7(5):3041-3049.

PMID: 38661721 PMC: 11366439. DOI: 10.1021/acsabm.4c00080.

Management of Central Venous Stenoses and Occlusions.

Kitrou P, Katsanos K, Karnabatidis D Cardiovasc Intervent Radiol. 2023; 46(9):1182-1191.

PMID: 37460644 PMC: 10471665. DOI: 10.1007/s00270-023-03461-7.

Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access maintenance.

DePietro D, Trerotola S Cardiovasc Diagn Ther. 2023; 13(1):233-259.

PMID: 36864970 PMC: 9971313. DOI: 10.21037/cdt-22-497.

References

Agarwal A . Central vein stenosis. Am J Kidney Dis. 2013; 61(6):1001-15. DOI: 10.1053/j.ajkd.2012.10.024. View

Massmann A, Fries P, Obst-Gleditsch K, Minko P, Shayesteh-Kheslat R, Buecker A . Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas. J Endovasc Ther. 2015; 22(1):74-9. DOI: 10.1177/1526602814566907. View

Kennedy S, Mafeld S, Baerlocher M, Jaberi A, Rajan D . Drug-Coated Balloon Angioplasty in Hemodialysis Circuits: A Systematic Review and Meta-Analysis. J Vasc Interv Radiol. 2019; 30(4):483-494.e1. DOI: 10.1016/j.jvir.2019.01.012. View

Kocaaslan C, Oztekin A, Bademci M, Denli Yalvac E, Bulut N, Aydin E . A retrospective comparison analysis of results of drug-coated balloon versus plain balloon angioplasty in treatment of juxta-anastomotic de novo stenosis of radiocephalic arteriovenous fistulas. J Vasc Access. 2019; 21(5):596-601. DOI: 10.1177/1129729819893205. View

Kitrou P, Papadimatos P, Spiliopoulos S, Katsanos K, Christeas N, Brountzos E . Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial. J Vasc Interv Radiol. 2017; 28(6):811-817. DOI: 10.1016/j.jvir.2017.03.007. View

Liao M, Chen M, Hsieh M, Yeh N, Chien K, Lin C . Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2020; 15(4):e0231463. PMC: 7156061. DOI: 10.1371/journal.pone.0231463. View

Gulcu A, Sarioglu O, Peker A, Alatas O . Drug-Eluting Balloon Angioplasty for Juxta-Anastomotic Stenoses in Distal Radiocephalic Hemodialysis Fistulas: Long-Term Patency Results. Cardiovasc Intervent Radiol. 2019; 42(6):835-840. DOI: 10.1007/s00270-019-02213-w. View

Kitrou P, Steinke T, El Hage R, Ponce P, Lucatelli P, Katsanos K . Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Vascular Access: Results From a European, Multicenter, Single-Arm Retrospective Analysis. J Endovasc Ther. 2021; 28(3):442-451. DOI: 10.1177/15266028211007471. View

Moreno-Sanchez T, Moreno-Ramirez M, Machancoses F, Pardo-Moreno P, Navarro-Vergara P, Garcia-Revillo J . Efficacy of Paclitaxel Balloon for Hemodialysis Stenosis Fistulae After One Year Compared to High-Pressure Balloons: A Controlled, Multicenter, Randomized Trial. Cardiovasc Intervent Radiol. 2019; 43(3):382-390. DOI: 10.1007/s00270-019-02372-w. View

10.

Kitrou P, Spiliopoulos S, Katsanos K, Papachristou E, Siablis D, Karnabatidis D . Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2014; 26(3):348-54. DOI: 10.1016/j.jvir.2014.11.003. View

11.

Trerotola S, Lawson J, Roy-Chaudhury P, Saad T . Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial. Clin J Am Soc Nephrol. 2018; 13(8):1215-1224. PMC: 6086699. DOI: 10.2215/CJN.14231217. View

12.

Tozzi M, Franchin M, Savio D, Comelli S, Di Maggio L, Carbonari L . Drug-coated balloon angioplasty in failing haemodialysis arteriovenous shunts: 12-month outcomes in 200 patients from the Aperto Italian registry. J Vasc Access. 2019; 20(6):733-739. DOI: 10.1177/1129729819848609. View

13.

Lucev J, Breznik S, Dinevski D, Ekart R, Rupreht M . Endovascular Treatment of Haemodialysis Arteriovenous Fistula with Drug-Coated Balloon Angioplasty: A Single-Centre Study. Cardiovasc Intervent Radiol. 2018; 41(6):882-889. DOI: 10.1007/s00270-018-1942-z. View

14.

Kim J, Kim J, Byun S, Kang J, Shin J . Paclitaxel-Coated Balloon versus Plain Balloon Angioplasty for Dysfunctional Autogenous Radiocephalic Arteriovenous Fistulas: A Prospective Randomized Controlled Trial. Korean J Radiol. 2020; 21(11):1239-1247. PMC: 7462765. DOI: 10.3348/kjr.2020.0067. View

15.

Kitrou P, Katsanos K, Karnabatidis D . New Evidence to Support the Use of Drug Coated Balloons in the Treatment of Dysfunctional Vascular Access. Eur J Vasc Endovasc Surg. 2021; 61(4):540-541. DOI: 10.1016/j.ejvs.2021.01.016. View

16.

Haskal Z, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S . Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010; 362(6):494-503. DOI: 10.1056/NEJMoa0902045. View

17.

Irani F, Teo T, Tay K, Yin W, Win H, Gogna A . Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty. Radiology. 2018; 289(1):238-247. DOI: 10.1148/radiol.2018170806. View

18.

Jaffer O, Gibbs P, Gibson M, Gilbert J, Hanko J, Jeevaratnam P . A UK Expert Consensus Approach for Managing Symptomatic Arteriovenous Fistula (AVF) Stenosis in Haemodialysis Patients. Cardiovasc Intervent Radiol. 2021; 44(11):1736-1746. DOI: 10.1007/s00270-021-02875-5. View

19.

Lai C, Fang H, Tseng C, Liu C, Mar G . Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study. J Vasc Interv Radiol. 2014; 25(4):535-41. DOI: 10.1016/j.jvir.2013.12.014. View

20.

Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D . Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012; 19(2):263-72. DOI: 10.1583/11-3690.1. View